181 related articles for article (PubMed ID: 17309880)
1. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation.
Schneider BL; Seehus CR; Capowski EE; Aebischer P; Zhang SC; Svendsen CN
Hum Mol Genet; 2007 Mar; 16(6):651-66. PubMed ID: 17309880
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
[TBL] [Abstract][Full Text] [Related]
5. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.
Furukawa K; Matsuzaki-Kobayashi M; Hasegawa T; Kikuchi A; Sugeno N; Itoyama Y; Wang Y; Yao PJ; Bushlin I; Takeda A
J Neurochem; 2006 May; 97(4):1071-7. PubMed ID: 16606366
[TBL] [Abstract][Full Text] [Related]
7. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
Moussa CE; Wersinger C; Tomita Y; Sidhu A
Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
[TBL] [Abstract][Full Text] [Related]
8. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
9. The embryonic midbrain directs neuronal specification of embryonic stem cells at early stages of differentiation.
Baizabal JM; Covarrubias L
Dev Biol; 2009 Jan; 325(1):49-59. PubMed ID: 18929554
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
[TBL] [Abstract][Full Text] [Related]
11. Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons.
Ko JY; Park CH; Koh HC; Cho YH; Kyhm JH; Kim YS; Lee I; Lee YS; Lee SH
J Neurochem; 2007 Nov; 103(4):1417-29. PubMed ID: 17854346
[TBL] [Abstract][Full Text] [Related]
12. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
13. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
Park SS; Lee D
Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
[TBL] [Abstract][Full Text] [Related]
14. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain.
Eslamboli A; Romero-Ramos M; Burger C; Bjorklund T; Muzyczka N; Mandel RJ; Baker H; Ridley RM; Kirik D
Brain; 2007 Mar; 130(Pt 3):799-815. PubMed ID: 17303591
[TBL] [Abstract][Full Text] [Related]
15. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
[TBL] [Abstract][Full Text] [Related]
17. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology.
Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M
Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718
[TBL] [Abstract][Full Text] [Related]
18. Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.
Shintani A; Nakao N; Kakishita K; Itakura T
J Neurosci Res; 2008 Oct; 86(13):2829-38. PubMed ID: 18561325
[TBL] [Abstract][Full Text] [Related]
19. Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons.
Young A; Assey KS; Sturkie CD; West FD; Machacek DW; Stice SL
J Neurosci Res; 2010 Nov; 88(15):3222-32. PubMed ID: 20857516
[TBL] [Abstract][Full Text] [Related]
20. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
Lev N; Melamed E; Offen D
Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]